METHOD FOR INDIVIDUAL ASSESSMENT OF PATIENTS TO ESTABLISH FACT OF CHRONIC CARDIAC INSUFFICIENCY SUFFERED Russian patent published in 2015 - IPC A61B5/00 A61B5/02 A61B5/107 G01N33/48 

FIELD: medicine.

SUBSTANCE: patients are assessed individually to establish the fact of chronic cardiac insufficiency (CCI) suffered by detecting: age, height, weight, Quetelet index, Brock constant, systolic blood pressure, diastolic blood pressure, triglycerides, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, low-density lipoprotein cholesterol to total cholesterol ratio, very low-density lipoprotein cholesterol, high-density lipoprotein cholesterol to low-density lipoprotein cholesterol ratio, sum of the very low-density lipoprotein cholesterol and high-density lipoprotein cholesterol to low-density lipoprotein cholesterol ratio, atherogenic index, alanine aminotransferase, aspartate aminotransferase, aspartate aminotransferase to alanine aminotransferase ratio, lactate dehydrogenase, glucose, α-amylase, total protein, albumin, uric acid, carbamide, creatinine, creatinine kinase, alkaline phosphatase, total bilirubin, conjugated bilirubin, ADP-induced thrombocyte aggregation, thrombocyte count, mean thrombocyte volume, erythrocyte count, mean erythrocyte volume, erythrocyte volume distribution, haematocrit, haemoglobin, mean corpuscular haemoglobin, mean corpuscular haemoglobin concentration, leukocyte count, segmented neutrophil percentage, eosinophil percentage, basophile percentage, lymphocyte percentage, monocyte percentage and displacement constant. The derived discriminator functions are used to establish the fact of the absence of CCI, the first stage of CCI, or the second stage of CCI.

EFFECT: method enables assessing the patients to establish the fact of CCI by determining the significant parameters.

3 dwg, 2 tbl, 1 ex